Fisher, 2002, Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis, Mycologia, 94, 73, 10.1080/15572536.2003.11833250
Cox, 2004, Coccidioidomycosis: host response and vaccine development, Clin Microbiol Rev, 17, 804, 10.1128/CMR.17.4.804-839.2004
Cordeiro, 2008, Twelve years of coccidioidomycosis in Ceará State. Northeast Brazil: epidemiologic and diagnostic aspects, Diagn Microbiol Infect Dis
DiCaudo DJ. Coccidioidomycosis: a review and update. J Am Acad Dermatol 2006;55:929–42; quiz 943–5.
Cortez, 2003, Successful treatment of coccidioidal meningitis with voriconazole, Clin Infect Dis, 36, 1619, 10.1086/375235
Stevens, 2007, Posaconazole therapy for chronic refractory coccidioidomycosis, Chest, 132, 952, 10.1378/chest.07-0114
Antony, 2004, Use of the echinocandins (caspofungin) in the treatment of disseminated coccidioidomycosis in a renal transplant recipient, Clin Infect Dis, 239, 879, 10.1086/423811
de Aquiar Cordeiro, 2006, In vitro inhibitory effect of antituberculosis drugs on clinical and environmental strains of Coccidioides posadasii, J Antimicrob Chemother, 58, 575, 10.1093/jac/dkl290
National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A. Wayne, PA: NCCLS; 2002.
Odds, 2003, Synergy, antagonism, and what the chequerboard puts between them, J Antimicrob Chemother, 52, 1, 10.1093/jac/dkg301
Antony, 2006, Successful use of combination antifungal therapy in the treatment of coccidioides meningitis, J Natl Med Assoc, 98, 940
Shubitz, 2006, Efficacy of ambruticin analogs in a murine model of coccidioidomycosis, Antimicrob Agents Chemother, 50, 3467, 10.1128/AAC.00670-06
Zhang, 2005, The magic bullets and tuberculosis drug targets, Annu Rev Pharmacol Toxicol, 45, 529, 10.1146/annurev.pharmtox.45.120403.100120
El-Azizi, 2007, Enhancement of the in vitro activity of amphotericin B against the biofilms of non-albicans Candida spp. by rifampicin and doxycycline, J Med Microbiol, 56, 645, 10.1099/jmm.0.46952-0
Baciewicz, 2008, Update on rifampin and rifabutin drug interactions, Am J Med Sci, 335, 126, 10.1097/MAJ.0b013e31814a586a